Chemoinformaics analysis of 2-hydroxybutanedioic acid
| Molecular Weight | 134.087 | nRot | 3 |
| Heavy Atom Molecular Weight | 128.039 | nRig | 2 |
| Exact Molecular Weight | 134.022 | nRing | 0 |
| Solubility: LogS | 0.114 | nHRing | 0 |
| Solubility: LogP | -1.688 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 15 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 14.6908 |
| nHD | 3 | BPOL | 7.75524 |
| QED | 0.317 |
| Synth | 2.893 |
| Natural Product Likeliness | 0.81 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.066 |
| HIA | 0.969 |
| CACO-2 | -5.967 |
| MDCK | 0.00749337 |
| BBB | 0.642 |
| PPB | 0.168223 |
| VDSS | 0.278 |
| FU | 0.760287 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.043 |
| CYP2c19-inh | 0.032 |
| CYP2c19-sub | 0.051 |
| CYP2c9-inh | 0.015 |
| CYP2c9-sub | 0.392 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.132 |
| CYP3a4-inh | 0.011 |
| CYP3a4-sub | 0.027 |
| CL | 3.028 |
| T12 | 0.852 |
| hERG | 0.027 |
| Ames | 0.02 |
| ROA | 0.009 |
| SkinSen | 0.264 |
| Carcinogencity | 0.013 |
| EI | 0.985 |
| Respiratory | 0.394 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.953667 |